Item 7.01 Regulation FD Disclosure

On June 9, 2009, CareFusion Corporation ("CareFusion"), the entity that is currently a wholly owned subsidiary of Cardinal Health, Inc. (the "Company") and that is expected to become public as a result of the planned spin-off of the Company's clinical and medical products businesses, issued a press release announcing the filing of a second amendment to its Form 10 registration statement, which includes the names of the persons who are expected to join CareFusion's board of directors and a discussion of CareFusion's progress toward complying with the Amended Consent Decree for Condemnation and Permanent Injunction (the "Amended Consent Decree") between a subsidiary of the Company and the U.S. Food and Drug Administration (the "FDA"). A copy of the news release is included as Exhibit 99.1 to this report.

Item 8.01 Other Events

As previously reported, on April 24, 2009, the Company submitted the corrective action plan required by the Amended Consent Decree. On June 2, 2009, the FDA notified the Company that the corrective action plan was acceptable and that the Company should begin implementation of the plan. Also as previously reported, on April 24, 2009, an independent expert provided a certification to the FDA indicating that the infusion pump operations are in conformity with the Federal Food, Drug and Cosmetic Act, which meets the requirements of the original Consent Decree. On June 2, 2009, the independent expert provided a certification to the FDA on the remainder of the items required by the Amended Consent Decree. See the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2009 filed on May 7, 2009 and Amendment No. 2 to CareFusion's Form 10 registration statement filed on June 9, 2009 for additional information on this matter.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 News release issued by CareFusion Corporation on June 9, 2009.

- 2 -

---